Cim Investment Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Cim Investment Management Inc

$321 Million
Q2 2024

A detailed history of Cim Investment Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cim Investment Management Inc holds 468 shares of REGN stock, worth $345,384. This represents 0.15% of its overall portfolio holdings.

Number of Shares

468

Previous 471 0.64%

Holding current value

$345,384

Previous $453,000 8.39%

% of portfolio

0.15%

Previous 0.14%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$883.2 - $1071.19 $2,649 - $3,213	-3 Reduced 0.64%	468 $491,000
Q4 2023 Feb 15, 2024	SELL	$775.18 - $881.7 $155,036 - $176,340	-200 Reduced 29.81%	471 $413,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $7,616 - $9,288	-11 Reduced 1.61%	671 $552,000
Q2 2023 Aug 09, 2023	BUY	$700.03 - $830.35 $1,400 - $1,660	2 Added 0.29%	682 $490,000
Q1 2023 May 16, 2023	BUY	$680.49 - $826.97 $76,214 - $92,620	112 Added 19.72%	680 $558,000
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $7,058 - $7,663	-10 Reduced 1.73%	568 $409,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $13,775 - $17,383	24 Added 4.33%	578 $398,000
Q2 2022 Sep 02, 2022	SELL	$548.35 - $738.84 $1,645 - $2,216	-3 Reduced 0.54%	554 $327,000
Q1 2022 May 17, 2022	SELL	$595.12 - $698.43 $300,535 - $352,707	-505 Reduced 47.55%	557 $389,000
Q4 2021 May 19, 2022	SELL	$543.48 - $670.97 $587,501 - $725,318	-1,081 Reduced 50.44%	1,062 $671,000
Q4 2021 Feb 02, 2022	BUY	$543.48 - $670.97 $577,175 - $712,570	1,062 Added 98.24%	2,143 $1.33 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $3,444 - $4,085	-6 Reduced 0.55%	1,081 $654,000
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $8,510 - $10,053	-18 Reduced 1.63%	1,087 $607,000
Q1 2021 May 20, 2021	SELL	$446.73 - $548.2 $17,869 - $21,928	-40 Reduced 3.49%	1,105 $523,000
Q4 2020 Feb 17, 2021	BUY	$478.3 - $607.98 $547,653 - $696,137	1,145 New	1,145 $553,000
Q1 2020 May 22, 2020	SELL	$336.18 - $494.43 $334,835 - $492,452	-996 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $28,713 - $33,430	-105 Reduced 9.54%	996 $276,000
Q2 2019 Aug 08, 2019	BUY	$299.6 - $414.82 $12,583 - $17,422	42 Added 3.97%	1,101 $345,000
Q4 2018 Feb 05, 2019	SELL	$335.82 - $403.04 $14,776 - $17,733	-44 Reduced 3.99%	1,059 $396,000
Q2 2018 Aug 07, 2018	SELL	$284.6 - $344.99 $9,107 - $11,039	-32 Reduced 2.82%	1,103 $381,000
Q1 2018 May 10, 2018	SELL	$315.82 - $393.78 $8,842 - $11,025	-28 Reduced 2.41%	1,135 $391,000
Q4 2017 Feb 13, 2018	BUY	$358.63 - $469.95 $417,086 - $546,551	1,163	1,163 $437,000

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cim Investment Management Inc with notifications on news.

Account

Cim Investment Management Inc Regeneron Pharmaceuticals, Inc. Transaction History